FBXW7 and acute lymphoblastic leukemia: The expression levels of miR‐32 are significantly higher in patients with T‐ALL than in healthy individuals, and miR‐32 inhibits FBXW7 expression by targeting the 3′‐UTR of FBXW7; thus, miR‐32 and FBXW7 may become potential targets for the diagnosis and treatment of acute leukaemia.65